Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2000 Apr;9(4):345-9.

2.

Insulin-like growth factor-I and binding protein-3 and risk of cancer.

Giovannucci E.

Horm Res. 1999;51 Suppl 3:34-41. Review.

PMID:
10592442
3.

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.

Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M.

Lancet. 2004 Apr 24;363(9418):1346-53. Review.

PMID:
15110491
4.

Acromegaly and cancer.

Jenkins PJ.

Horm Res. 2004;62 Suppl 1:108-15. Review.

PMID:
15761242
5.

Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis.

Chi F, Wu R, Zeng YC, Xing R, Liu Y.

Mol Biol Rep. 2013 May;40(5):3583-90. doi: 10.1007/s11033-012-2432-z. Epub 2012 Dec 27. Review.

PMID:
23269623
6.

Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma.

Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, Ran ZH, Xiao SD.

J Dig Dis. 2011 Aug;12(4):234-44. doi: 10.1111/j.1751-2980.2011.00504.x. Review.

PMID:
21791018
7.

Cancers associated with acromegaly.

Jenkins PJ.

Neuroendocrinology. 2006;83(3-4):218-23. Epub 2006 Oct 13. Review.

PMID:
17047386
8.

Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis.

Wilschut JA, Habbema JD, Ramsey SD, Boer R, Looman CW, van Ballegooijen M.

Cancer Causes Control. 2010 Dec;21(12):2287-93. doi: 10.1007/s10552-010-9654-y. Epub 2010 Oct 28. Review.

PMID:
20981482
9.

Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?

Holly JM, Gunnell DJ, Davey Smith G.

J Endocrinol. 1999 Sep;162(3):321-30. Review.

10.

Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk?

McKeown-Eyssen G.

Cancer Epidemiol Biomarkers Prev. 1994 Dec;3(8):687-95. Review.

11.

The natural history of colorectal cancer. Opportunities for intervention.

Winawer SJ, Zauber AG, Stewart E, O'Brien MJ.

Cancer. 1991 Feb 15;67(4 Suppl):1143-9. Review.

12.

The insulin-like growth factor axis: A biological mechanism linking physical activity to colorectal cancer survival.

Sax AT, Jenkins DG, Devin JL, Hughes GI, Bolam KA, Skinner TL.

Cancer Epidemiol. 2014 Aug;38(4):455-9. doi: 10.1016/j.canep.2014.05.011. Epub 2014 Jun 23. Review.

PMID:
24968815
13.

The causes of ordinary colorectal adenomas: the key to the control of colorectal cancer?

Kune GA, Vitetta L.

J R Soc Med. 1995 Nov;88(11):625-8. Review. No abstract available.

14.

[Relationship between Barrett esophagus and colorectal tumors].

Cauvin JM, Goldfain D, Le Rhun M, Robaszkiewicz M, Cadiot G, Carpentier S, Rotenberg A, Mignon M, Boyer J, Galmiche JP.

Gastroenterol Clin Biol. 1994;18(1 Pt 2):D53-5. Review. French. No abstract available.

PMID:
8013785
15.

C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.

Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA.

Int J Cancer. 2008 Sep 1;123(5):1133-40. doi: 10.1002/ijc.23606. Review.

16.

Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.

Muc-Wierzgoń M, Nowakowska-Zajdel E, Dzięgielewska-Gęsiak S, Kokot T, Klakla K, Fatyga E, Grochowska-Niedworok E, Waniczek D, Wierzgoń J.

World J Gastroenterol. 2014 Aug 7;20(29):9759-74. doi: 10.3748/wjg.v20.i29.9759. Review.

17.

Is there a role for IGF-1 in the development of second primary cancers?

Shanmugalingam T, Bosco C, Ridley AJ, Van Hemelrijck M.

Cancer Med. 2016 Nov;5(11):3353-3367. doi: 10.1002/cam4.871. Epub 2016 Oct 13. Review.

Supplemental Content

Support Center